Home › Funds › James Hambro & Partners LLP › ISRG
James Hambro & Partners LLP position in ISRG
INTUITIVE SURGICAL INC · Health Care
James Hambro & Partners LLP reported holding 238,649 shares of ISRG (INTUITIVE SURGICAL INC) in its Q3 2026 13F filing — a position valued at US$97.0M, representing 3.38% of its reported portfolio and ranking #14 among its reported holdings. James Hambro & Partners LLP has disclosed ISRG holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How James Hambro & Partners LLP's ISRG position evolved
James Hambro & Partners LLP first disclosed a stake in ISRG in Q3 2023 at 217,973 shares (US$63.7M). The position peaked in Q4 2025 at 239,066 shares, worth US$135.4M. Across 13 filings, James Hambro & Partners LLP increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 238,649 shares valued at US$97.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 217.97K | $63.72M | New |
| Q4 2023 | 235.82K | $79.56M | Add |
| Q1 2024 | 239.44K | $95.51M | Add |
| Q2 2024 | 249.79K | $111.13M | Add |
| Q3 2024 | 244.81K | $120.28M | Reduce |
| Q4 2024 | 242.62K | $126.66M | Reduce |
| Q1 2025 | 224.07K | $110.96M | Reduce |
| Q2 2025 | 233.65K | $127.00M | Add |
| Q3 2025 | 236.54K | $105.78M | Add |
| Q4 2025 | 239.07K | $135.43M | Add |
| Q1 2026 | 233.25K | $107.58M | Reduce |
| Q2 2026 | 238.83K | $94.96M | Add |
| Q3 2026 | 238.65K | $97.04M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ISRG and 13F data
ISRG (INTUITIVE SURGICAL INC) is a Health Care company. 31 other funds we track also report a position in ISRG — the largest reported positions include Invesco Ltd (US$4.71B), PRICE T ROWE ASSOCIATES INC /MD/ (US$4.48B), ALLIANCEBERNSTEIN L.P. (US$1.67B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ISRG
- Invesco Ltd 11.84M sh · $4.71B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 11.26M sh · $4.48B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.63M sh · $1.67B · Q2 2026
- Arrowstreet Capital 3.74M sh · $1.49B · Q2 2026
- JENNISON ASSOCIATES LLC 3.67M sh · $1.46B · Q2 2026
- Baillie Gifford & Co 2.52M sh · $1.00B · Q2 2026
More on James Hambro & Partners LLP
FAQ
How long has James Hambro & Partners LLP held ISRG?
James Hambro & Partners LLP has disclosed ISRG holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is James Hambro & Partners LLP's current position in ISRG?
As of Q3 2026, James Hambro & Partners LLP holds 238.65K shares of ISRG (INTUITIVE SURGICAL INC), valued at $97.04M, representing 3.38% of its reported portfolio and ranking #14.
Has James Hambro & Partners LLP been buying or selling ISRG?
In the latest 13F filing (Q3 2026), James Hambro & Partners LLP held unchanged its position in ISRG. The position peaked in Q4 2025 at 239.07K shares.
Which other funds hold ISRG?
Other major institutional holders of ISRG include Invesco Ltd, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.